Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 6,354,000 | 6,664,000 | 6,406,000 | 5,823,000 | 5,491,000 |
| Cost of Goods | 1,420,000 | 1,378,000 | 1,351,000 | 1,063,000 | 1,129,000 |
| Gross Profit | 4,934,000 | 5,286,000 | 5,055,000 | 4,760,000 | 4,362,000 |
| Operating Expenses | 3,714,000 | 4,862,000 | 4,243,000 | 4,267,000 | 3,265,000 |
| Operating Income | 1,220,000 | 424,000 | 812,000 | 493,000 | 1,097,000 |
| Interest Expense | 332,000 | 321,000 | 353,000 | 361,000 | 367,000 |
| Other Income | 47,000 | 137,000 | -50,000 | 9,000 | 28,000 |
| Pre-tax Income | 935,000 | 240,000 | 409,000 | 141,000 | 758,000 |
| Income Tax | 185,000 | -37,000 | 129,000 | 34,000 | 195,000 |
| Net Income Continuous | 750,000 | 277,000 | 280,000 | 107,000 | 563,000 |
| Minority Interests | 30,000 | 36,000 | 19,000 | 23,000 | 30,000 |
| Net Income | $780,000 | $313,000 | $299,000 | $130,000 | $593,000 |
| EPS Basic Total Ops | 0.59 | 0.24 | 0.23 | 0.09 | 0.47 |
| EPS Basic Continuous Ops | 0.59 | 0.24 | 0.23 | 0.09 | 0.47 |
| EPS Diluted Total Ops | 0.59 | 0.24 | 0.23 | 0.09 | 0.47 |
| EPS Diluted Continuous Ops | 0.59 | 0.24 | 0.23 | 0.09 | 0.47 |
| EBITDA(a) | $2,108,000 | $2,204,000 | $1,478,000 | $1,229,000 | $1,801,000 |